Hepatitis C: Grading and Staging by MR

This study has been completed.

First Received on April 24, 2003. Last Updated on March 17, 2010 History of Changes

Sponsor:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:	NCT00059397

Purpose

To compare MR imaging findings with biopsy for grading and staging early hepatitis C.

Condition
Hepatitis

Study Type:	Observational
Study Design:	Time Perspective: Prospective
Official Title:	Hepatitis C: Grading and Staging by MR

Resource links provided by NLM:

MedlinePlus related topics: Hepatitis Hepatitis A Hepatitis C

Drug Information available for: Hepatitis A Vaccines

U.S. FDA Resources

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Estimated Enrollment:	80
Study Start Date:	April 2003

Eligibility

Criteria

Referral only

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00059397

Locations

United States, Pennsylvania
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107

Sponsors and Collaborators

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00059397 History of Changes
Other Study ID Numbers:	R03 (DK62765) (completed 2007)
Study First Received:	April 24, 2003
Last Updated:	March 17, 2010
Health Authority:	United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Hepatitis C

Additional relevant MeSH terms:

Hepatitis
Hepatitis A
Hepatitis C
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human

Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Flaviviridae Infections

ClinicalTrials.gov processed this record on February 12, 2012